53 related articles for article (PubMed ID: 38699737)
21. Fabricating a PDA-Liposome Dual-Film Coated Hollow Mesoporous Silica Nanoplatform for Chemo-Photothermal Synergistic Antitumor Therapy.
Fan C; Wang X; Wang Y; Xi Z; Wang Y; Zhu S; Wang M; Xu L
Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111615
[TBL] [Abstract][Full Text] [Related]
22. Thermal-triggered loading and GSH-responsive releasing property of HBc particles for drug delivery.
Li Z; Ma Y; Ren Y; Lin X; Su Z; Zhang S
J Control Release; 2023 Oct; 362():784-796. PubMed ID: 37003490
[TBL] [Abstract][Full Text] [Related]
23. Mesoporous Silica Nanoparticles-Based Nanoplatforms: Basic Construction, Current State, and Emerging Applications in Anticancer Therapeutics.
Feng Y; Liao Z; Li M; Zhang H; Li T; Qin X; Li S; Wu C; You F; Liao X; Cai L; Yang H; Liu Y
Adv Healthc Mater; 2023 Jun; 12(16):e2201884. PubMed ID: 36529877
[TBL] [Abstract][Full Text] [Related]
24. A review on the latest developments of mesoporous silica nanoparticles as a promising platform for diagnosis and treatment of cancer.
Ahmadi F; Sodagar-Taleghani A; Ebrahimnejad P; Pouya Hadipour Moghaddam S; Ebrahimnejad F; Asare-Addo K; Nokhodchi A
Int J Pharm; 2022 Sep; 625():122099. PubMed ID: 35961417
[TBL] [Abstract][Full Text] [Related]
25. Current trends in smart mesoporous silica-based nanovehicles for photoactivated cancer therapy.
Wang K; Lu J; Li J; Gao Y; Mao Y; Zhao Q; Wang S
J Control Release; 2021 Nov; 339():445-472. PubMed ID: 34637819
[TBL] [Abstract][Full Text] [Related]
26. Advances in clinical immunotherapy for gastric cancer.
Li K; Zhang A; Li X; Zhang H; Zhao L
Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188615. PubMed ID: 34403771
[TBL] [Abstract][Full Text] [Related]
27. Effect of Paclitaxel/etoposide co-loaded polymeric nanoparticles on tumor size and survival rate in a rat model of glioblastoma.
Maleki H; Hosseini Najafabadi MR; Webster TJ; Hadjighassem MR; Sadroddiny E; Ghanbari H; Khosravani M; Adabi M
Int J Pharm; 2021 Jul; 604():120722. PubMed ID: 34022255
[TBL] [Abstract][Full Text] [Related]
28. Targeted and immunotherapy in the era of personalised gastric cancer treatment.
Catanese S; Lordick F
Best Pract Res Clin Gastroenterol; 2021; 50-51():101738. PubMed ID: 33975679
[TBL] [Abstract][Full Text] [Related]
29. A Smart Multifunctional Nanoparticle for Enhanced Near-Infrared Image-Guided Photothermal Therapy Against Gastric Cancer.
Shao J; Liang R; Ding D; Zheng X; Zhu X; Hu S; Wei H; Wei B
Int J Nanomedicine; 2021; 16():2897-2915. PubMed ID: 33907399
[TBL] [Abstract][Full Text] [Related]
30. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
[TBL] [Abstract][Full Text] [Related]
31. Redox- and MMP-2-sensitive drug delivery nanoparticles based on gelatin and albumin for tumor targeted delivery of paclitaxel.
Zhou K; Zhu Y; Chen X; Li L; Xu W
Mater Sci Eng C Mater Biol Appl; 2020 Sep; 114():111006. PubMed ID: 32993973
[TBL] [Abstract][Full Text] [Related]
32. Gastric cancer: a comprehensive review of current and future treatment strategies.
Sexton RE; Al Hallak MN; Diab M; Azmi AS
Cancer Metastasis Rev; 2020 Dec; 39(4):1179-1203. PubMed ID: 32894370
[TBL] [Abstract][Full Text] [Related]
33. Targeted Therapies in Advanced Gastric Cancer.
Patel TH; Cecchini M
Curr Treat Options Oncol; 2020 Jul; 21(9):70. PubMed ID: 32725377
[TBL] [Abstract][Full Text] [Related]
34. Gastric Cancer: Epidemiology, Risk Factors, Classification, Genomic Characteristics and Treatment Strategies.
Machlowska J; Baj J; Sitarz M; Maciejewski R; Sitarz R
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32512697
[TBL] [Abstract][Full Text] [Related]
35. Mitoxantrone as photothermal agents for ultrasound/fluorescence imaging-guided chemo-phototherapy enhanced by intratumoral H
Wang Y; Zhang J; Lv X; Wang L; Zhong Z; Yang DP; Si W; Zhang T; Dong X
Biomaterials; 2020 Sep; 252():120111. PubMed ID: 32422493
[TBL] [Abstract][Full Text] [Related]
36. Design of new protein drug delivery system (PDDS) with photoactive compounds as a potential application in the treatment of glioblastoma brain cancer.
de Melo MT; Piva HL; Tedesco AC
Mater Sci Eng C Mater Biol Appl; 2020 May; 110():110638. PubMed ID: 32204072
[TBL] [Abstract][Full Text] [Related]
37. Recent advances in functional mesoporous silica-based nanoplatforms for combinational photo-chemotherapy of cancer.
Cheng YJ; Hu JJ; Qin SY; Zhang AQ; Zhang XZ
Biomaterials; 2020 Feb; 232():119738. PubMed ID: 31901695
[TBL] [Abstract][Full Text] [Related]
38. ROS-responsive nanoparticles based on amphiphilic hyperbranched polyphosphoester for drug delivery: Light-triggered size-reducing and enhanced tumor penetration.
Jin H; Zhu T; Huang X; Sun M; Li H; Zhu X; Liu M; Xie Y; Huang W; Yan D
Biomaterials; 2019 Aug; 211():68-80. PubMed ID: 31096162
[TBL] [Abstract][Full Text] [Related]
39. Simultaneous controlled release of 5-FU, DOX and PTX from chitosan/PLA/5-FU/g-C3N4-DOX/g-C3N4-PTX triaxial nanofibers for breast cancer treatment in vitro.
Habibi Jouybari M; Hosseini S; Mahboobnia K; Boloursaz LA; Moradi M; Irani M
Colloids Surf B Biointerfaces; 2019 Jul; 179():495-504. PubMed ID: 31005745
[TBL] [Abstract][Full Text] [Related]
40. Theranostic nanoparticles with tumor-specific enzyme-triggered size reduction and drug release to perform photothermal therapy for breast cancer treatment.
Liu R; Hu C; Yang Y; Zhang J; Gao H
Acta Pharm Sin B; 2019 Mar; 9(2):410-420. PubMed ID: 30976492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
